Alex Burton, Sabeena Beveridge, Nicholas Hardcastle, Silvio Malfitana, Janaka Madamperuma, Rick Franich
{"title":"Design and validation of a novel dosimetry phantom for motion management audits.","authors":"Alex Burton, Sabeena Beveridge, Nicholas Hardcastle, Silvio Malfitana, Janaka Madamperuma, Rick Franich","doi":"10.1002/acm2.70091","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We present a novel phantom design for conducting end-to-end dosimetry audits for respiratory motion management of two anatomical treatment sites. The design enables radiochromic film measurements of the dose administered to the target throughout the respiratory cycle (motion-included) and the dose delivered to the time-averaged motion of the phantom (motion-excluded) to be conducted simultaneously.</p><p><strong>Purpose: </strong>To demonstrate the phantom's utility in a dosimetry audit and capacity to detect errors by quantifying spatial and dosimetric reproducibility.</p><p><strong>Methods: </strong>Spatial and dosimetric reproducibility was quantified by repeat exposures using a simple lateral beam. Five exposures per measurement configuration were used. In each series of five measurements, the median film was used as the series reference to quantify the reproducibility of the remaining \"test films.\" Spatial reproducibility was quantified by comparing the position of isodose lines in two axes on the test films back to the series reference. Dosimetric reproducibility was quantified using gamma comparison between each test film and the series reference. Proof-of-concept of the motion-excluded measurement capability was also established by comparing all films to treatment planning system (TPS) calculated dose distributions.</p><p><strong>Results: </strong>Spatial reproducibility was better than 1 mm on all assessed metrics across all measurements. Film-to-film local gamma passing rates at 3%/0.6 mm were above 90% for all measurements. Film-to-TPS global gamma passing rates at 3%/1 mm were >95% in the motion-excluded measurement series', but <80% in the motion-included series, highlighting the utility of the motion-excluded measurements.</p><p><strong>Conclusions: </strong>Measurements were highly reproducible and of sufficient accuracy/reproducibility to facilitate multiple avenues of analysis in a prospective dosimetry audit. Motion-excluded measurements were directly comparable to the TPS dose distribution. Motion-included measurements may yield more clinically-relevant information about the actual dose administered to the target. This promises greater sensitivity to motion management-related errors, detectable in the setting of a dosimetry audit for motion management.</p>","PeriodicalId":14989,"journal":{"name":"Journal of Applied Clinical Medical Physics","volume":" ","pages":"e70091"},"PeriodicalIF":2.0000,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Applied Clinical Medical Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/acm2.70091","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Background: We present a novel phantom design for conducting end-to-end dosimetry audits for respiratory motion management of two anatomical treatment sites. The design enables radiochromic film measurements of the dose administered to the target throughout the respiratory cycle (motion-included) and the dose delivered to the time-averaged motion of the phantom (motion-excluded) to be conducted simultaneously.
Purpose: To demonstrate the phantom's utility in a dosimetry audit and capacity to detect errors by quantifying spatial and dosimetric reproducibility.
Methods: Spatial and dosimetric reproducibility was quantified by repeat exposures using a simple lateral beam. Five exposures per measurement configuration were used. In each series of five measurements, the median film was used as the series reference to quantify the reproducibility of the remaining "test films." Spatial reproducibility was quantified by comparing the position of isodose lines in two axes on the test films back to the series reference. Dosimetric reproducibility was quantified using gamma comparison between each test film and the series reference. Proof-of-concept of the motion-excluded measurement capability was also established by comparing all films to treatment planning system (TPS) calculated dose distributions.
Results: Spatial reproducibility was better than 1 mm on all assessed metrics across all measurements. Film-to-film local gamma passing rates at 3%/0.6 mm were above 90% for all measurements. Film-to-TPS global gamma passing rates at 3%/1 mm were >95% in the motion-excluded measurement series', but <80% in the motion-included series, highlighting the utility of the motion-excluded measurements.
Conclusions: Measurements were highly reproducible and of sufficient accuracy/reproducibility to facilitate multiple avenues of analysis in a prospective dosimetry audit. Motion-excluded measurements were directly comparable to the TPS dose distribution. Motion-included measurements may yield more clinically-relevant information about the actual dose administered to the target. This promises greater sensitivity to motion management-related errors, detectable in the setting of a dosimetry audit for motion management.
期刊介绍:
Journal of Applied Clinical Medical Physics is an international Open Access publication dedicated to clinical medical physics. JACMP welcomes original contributions dealing with all aspects of medical physics from scientists working in the clinical medical physics around the world. JACMP accepts only online submission.
JACMP will publish:
-Original Contributions: Peer-reviewed, investigations that represent new and significant contributions to the field. Recommended word count: up to 7500.
-Review Articles: Reviews of major areas or sub-areas in the field of clinical medical physics. These articles may be of any length and are peer reviewed.
-Technical Notes: These should be no longer than 3000 words, including key references.
-Letters to the Editor: Comments on papers published in JACMP or on any other matters of interest to clinical medical physics. These should not be more than 1250 (including the literature) and their publication is only based on the decision of the editor, who occasionally asks experts on the merit of the contents.
-Book Reviews: The editorial office solicits Book Reviews.
-Announcements of Forthcoming Meetings: The Editor may provide notice of forthcoming meetings, course offerings, and other events relevant to clinical medical physics.
-Parallel Opposed Editorial: We welcome topics relevant to clinical practice and medical physics profession. The contents can be controversial debate or opposed aspects of an issue. One author argues for the position and the other against. Each side of the debate contains an opening statement up to 800 words, followed by a rebuttal up to 500 words. Readers interested in participating in this series should contact the moderator with a proposed title and a short description of the topic